Prostate cancer trial aims to sharpen radiation with PET scans

NCT ID NCT06044857

Recruiting now Disease control Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Apr 25, 2026 · Last updated Apr 25, 2026

Summary

This early-phase study tests a personalized radiation approach for high-risk prostate cancer. It uses special PET scans to see how tumors respond to hormone therapy, then adjusts the radiation dose to target remaining cancer spots. The goal is to improve treatment precision and reduce side effects. About 20 participants will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

UT Southwestern Medical Center
NOT_YET_RECRUITING

Dallas, Texas, 75390, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75239, United States

Conditions

Explore the condition pages connected to this study.

PROSTATE ADENOCARCINOMA